Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - Acer Therapeutics Inc. | d890540dex231.htm |
| S-1/A - S-1/A - Acer Therapeutics Inc. | d890540ds1a.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Amendment No. 2 to the Registration Statement on Form S-1 (No. 333-238192) and related Prospectus of Acer Therapeutics Inc. of our report dated March 7, 2019 relating to the consolidated financial statements appearing in the Annual Report on Form 10-K of Acer Therapeutics Inc. for the year ended December 31, 2019.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
June 3, 2020